Key factors for best control of the systemic leakage during hyperthermic isolated limb perfusion (HILP) in ECC. A critical synthesis of our experience.
The L-PAM-ILP procedures under true hyperthermal regime (41.5-41.8 degrees C) require both close control of the physical parameters of the treatment (temperatures profiles and time duration, artero-venous pressure, perfusate flow rate) and medical rationale (drug, dosage, fractioning, timing). All the above essential procedures must be supported by rigorous methodology, reliable operation of the medical devices and apparatus and real-time monitoring of the treatment parameters. Real-time monitoring is essential for proper trimming and modulation of the parameters during treatment. This paper delineates the technical improvements that we have implemented for drug leakage monitoring and control in the systemic circulation aimed at improving the therapeutic efficacy and at reducing the occurrence of unexpected complications.
Pace
M
M
Dept. of Medical and Surgical Critical Care, University of Florence, Regional Reference Centre of Tuscany for Locoregional Perfusional Therapies in Oncology, Italy. mpace@unifi.it
Millanta
L
L
Gattai
R
R
Matteini
M
M
Vaggelli
L
L
Macera Mascitelli
E
E
Bechi
P
P
D010478:Chemotherapy, Cancer, Regional Perfusion; D005112:Extracorporeal Circulation; D005121:Extremities / Q000098:blood supply*; D006801:Humans; D006979:Hyperthermia, Induced; D010477:Perfusion